Summary
Updated Aug 31, 2026
Sands Capital Life Sciences Pulse Fund II, L.P. is 10% Owner of Inhibikase Therapeutics, Inc. (IKT). 1 SEC Form 4 filing on record, dated 24 November 2025. Most recent open-market trade: bought $3.00M of IKT on 24 November 2025. Lifetime open-market purchases: $3.00M.
Recent Transactions
1Every recent SEC Form 4 transaction Sands Capital Life Sciences Pulse Fund II, L.P. has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Sands Capital Life Sciences Pulse Fund II, L.P. go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. The typical open-market purchase is $3.00M (1 buy totaling $3.00M). The largest single buy on record is $3.00M of IKT in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Sands Capital Life Sciences Pulse Fund II, L.P.. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Roberto Bellini - $2.00M of IKT open-market activity on record
- Amit Munshi - $500K of IKT open-market activity on record
- Arvind Kush - $199K of IKT open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is Sands Capital Life Sciences Pulse Fund II, L.P.?
Sands Capital Life Sciences Pulse Fund II, L.P. is an investment firm, tracked as 10% Owner of Inhibikase Therapeutics, Inc. (IKT). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sands Capital Life Sciences Pulse Fund II, L.P. last file a Form 4?
The only primary Form 4 on record is dated 24 November 2025.
Has Sands Capital Life Sciences Pulse Fund II, L.P. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($3.00M) and 0 open-market sales across all tracked filings.
Where can I see all of Sands Capital Life Sciences Pulse Fund II, L.P.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Sands Capital Life Sciences Pulse Fund II, L.P. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial